FDA Awarded Aeterna Zentaris (AEZS) Special Protocol Assessment for Phase 3 Registration Trial in Endometrial Cancer with AEZS-108


Aeterna Zentaris Granted Patent by EPO for AEZS-130 in Growth Hormone Deficiency Diagnosis (AEZS, CPST)


Aeterna Zentaris and Hikma Pharmaceuticals Sign a Commercialization and Licensing Agreement for Lead Oncology Compound, Perifosine, for Middle East and North Africa (MENA) Region


(AEZS, CALL, FWLT) PennyOmega.com Watch List for Friday Nov. 25, 2011


Aeterna Zentaris Announces Favorable Top-Line Results of Completed Phase 3 Study on AEZS-130 as First Oral Diagnostic Test for Adult Growth Hormone Deficiency


  • Video

  • Hot stocks to watch!

    Starbucks Corp - SBUX

    Select Sector SPDR: Industrial Sector Fund - XLI

    Cleantech Transit, Inc. - CLNO.OB

    PowerShares QQQ - QQQQ

    Research In Motion Ltd - RIMM

    Intel Corporation - INTC

    Dynegy Inc Del - DYN

    Pfizer Inc - PFE

    Fifth Third Bancorp - FITB

    Atmel Corp - ATML

    Crown Equity Holdings Inc. - CRWE.OB

    EMC Corp - EMC

    Sirius XM Radio Inc - SIRI

    Mylan Laboratories Inc - MYL

    Microsoft Corporation - MSFT

    Weatherford Internation Lt - WFT

    Dell Inc - DELL

    Financial Select Sector SPDR ETF - XLF

    Corning Inc - GLW

    Mattel, Inc - MAT

    Level 3 Communications Inc - LVLT

    Wal-Mart Stores Inc - WMT

  •